the equity method is applied (Unit : Million Baht) Q2/2019 Q2/2018 % Change 6 Month 2019 6 Month 2018 % Change Sales and Service Income 516 467 10 1,001 934 7 Cost of Sales and Services 412 375 10 800
6.8 MB and THB 17.8 MB Q2/2020 and 2019 respectively, A decrease compared to the same period last year amount THB 10.9 MB, which mostly decreased from foreign exchange gains. Administrative expenses for
liabilities. The decrease for long term loan in year 2020 due to gradually paying off some balance of debt from the finance institution. Shareholder’s equity The Company’s shareholders equity as of the year
attributable to Equity holders of the Company in Q3/2019 and of the nine months of 2019 were of Bt255. 7 million and Bt779.7 million which decreased by Bt48.9 million or 16.1%(y-o-y) and decreased by Bt89.8
attributable to the Equity of the Company in Q2/2019 amounted to Bt176.1 million, a decrease of Bt66.2 million or 27.3%(y-o-y) and equivalent to earnings per share of Bt0.28. And in the first six months of the
46,154 46,319 43,763 Total liabilities million baht 13,680 14,428 13,205 equity’ Total shareholders million baht 32,474 31,891 30,558 Registered capital million baht 1,259 1,259 1,259 up capital-Paid
Operated by For the three-month period ended 31 March % Change Increase (Decrease) 2017 2016 THB mm % THB mm % Sales 1. Sales from dessert café Company 153.94 97.56 137.01 98.75 12.36 2. Sales from catering
year, mostly from revenue from UAC which increased Baht 977.69 million, which resulted in the increase in gross profit of Baht 20.62 million and the decrease in gross profit margin for 9-month period of
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
-187.69% Net profit (loss) attributable to equity holders 128 146 -18 -12.29% Net profit (loss) attributable to equity holders Margin (%) 2.20% 2.51% -0.31% http://www.aapico.com/ http://www.aapico.com/ 99